Lexaria Bioscience Corp (LEXX)
2.09
-0.07
(-3.24%)
USD |
NASDAQ |
Nov 22, 13:42
Lexaria Bioscience Profit Margin (Quarterly): -2.12K% for May 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2024 | -2.12K% |
| February 29, 2024 | -448.0% |
| November 30, 2023 | -779.6% |
| August 31, 2023 | -4.03K% |
| May 31, 2023 | -3.05K% |
| February 28, 2023 | -6.48K% |
| November 30, 2022 | -1.80K% |
| August 31, 2022 | -1.32K% |
| May 31, 2022 | -2.39K% |
| February 28, 2022 | -4.65K% |
| November 30, 2021 | -14.36K% |
| August 31, 2021 | -3.80K% |
| May 31, 2021 | -1.25K% |
| February 28, 2021 | |
| November 30, 2020 | -235.4% |
| August 31, 2020 | -617.3% |
| May 31, 2020 | -3.74K% |
| February 29, 2020 | -2.53K% |
| November 30, 2019 | -8.78K% |
| August 31, 2019 | -861.8% |
| May 31, 2019 | -1.96K% |
| February 28, 2019 | -7.48K% |
| November 30, 2018 | -3.16K% |
| August 31, 2018 | -1.26K% |
| May 31, 2018 | -2.44K% |
| Date | Value |
|---|---|
| February 28, 2018 | -801.6% |
| November 30, 2017 | -2.35K% |
| August 31, 2017 | -5.47K% |
| May 31, 2017 | -1.16K% |
| February 28, 2017 | -3.55K% |
| November 30, 2016 | -4.29K% |
| August 31, 2016 | -3.67K% |
| May 31, 2016 | -4.15K% |
| February 29, 2016 | -1.71K% |
| November 30, 2015 | -3.55K% |
| August 31, 2015 | -11.14K% |
| May 31, 2015 | -6.50K% |
| February 28, 2015 | -15.91K% |
| November 30, 2014 | |
| July 31, 2014 | -418.0% |
| April 30, 2014 | -293.9% |
| January 31, 2014 | -63.64% |
| October 31, 2013 | 14.74% |
| July 31, 2013 | -22.93% |
| April 30, 2013 | -18.76% |
| January 31, 2013 | -31.89% |
| October 31, 2012 | 6.70% |
| July 31, 2012 | 13.78% |
| April 30, 2012 | -160.2% |
| January 31, 2012 | -47.69% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.36K%
Minimum
Nov 2021
-235.4%
Maximum
Nov 2020
-3.47K%
Average
-2.46K%
Median
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
| ImmunoPrecise Antibodies Ltd | -75.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.31% |
| Return on Assets | -85.62% |
| Return on Invested Capital | -93.31% |
| Operating Margin (Quarterly) | -2.07K% |
| Return on Net Operating Assets | -87.96% |